Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Alembic Pharmaceuticals Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (367)
ARTG (148)
Prescription medicine registration (10)

Date

2025 (83)
2024 (10)
2023 (249)
2022 (10)
2021 (84)
2020 (22)
2019 (2)
2018 (17)
2017 (17)
2016 (3)
2015 (11)
2013 (11)
2012 (6)

Search

Sponsor content

525 result(s) found, displaying 141 to 150

ALEMBIC CANDESARTAN HCTZ 16/12.5 candesartan cilexetil 16 mg & hydrochlorothiazide 12.5 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

13 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
ALEMBIC CANDESARTAN HCTZ 32/25 candesartan cilexetil 32 mg & hydrochlorothiazide 25 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

13 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
CANDESARTAN HCTZ AGH 32/12.5 candesartan cilexetil 32 mg & hydrochlorothiazide 12.5 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

13 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
ALEMBIC CANDESARTAN HCTZ 32/12.5 candesartan cilexetil 32 mg & hydrochlorothiazide 12.5 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

13 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
TELMISARTAN HCT APPL 40/12.5mg telmisartan 40mg and hydrochlorothiazide 12.5mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
TELMISARTAN HCT APA 80/25mg telmisartan 80mg and hydrochlorothiazide 25mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
TELMISARTAN HCT APA 80/12.5mg telmisartan 80mg and hydrochlorothiazide 12.5mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
TELMISARTAN HCT APA 40/12.5mg telmisartan 40mg and hydrochlorothiazide 12.5mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
CANDLEMBIC HCTZ 32/12.5 candesartan cilexetil 32 mg & hydrochlorothiazide 12.5 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

13 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
CANDESARTAN HCTZ APA 32/25 candesartan cilexetil 32 mg & hydrochlorothiazide 25 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

13 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd

Pages

First page
Previous page
…
Page 11
Page 12
Page 13
Page 14
Current page 15
Page 16
Page 17
Page 18
Page 19
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.